EP3775165
Aðferðir við framleiðslu æxlisífarandi eitilfrumna og notkun þeirra í ónæmismeðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.6.2018EP published:
27.3.2024EP application number:
18745741.1
EP translation filed:
24.6.2024Grant published:
15.7.2024EPO information:
European Patent Register
Max expiry date:
28.6.2038Expiry date:
28.6.2026Next due date:
30.6.2026
Title in English:
PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPYLanguage of the patent:
English
Timeline
Today
29.6.2018EP application
27.3.2024EP Publication
24.6.2024Translation submitted
15.7.2024Registration published
28.6.2026Expires
Owner
Name:
Iovance Biotherapeutics, Inc.Address:
825 Industrial Road Suite 400, San Carlos, CA 94070, US
Inventor
Name:
WARDELL, SethAddress:
San Carlos CA 94070, US
Name:
BENDER, JamesAddress:
Rancho Santa Margarita, CA 92688, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201815940901Date:
29.3.2018Country:
US
Classification
Categories:
C12N 5/0783, A01N 1/02, A61K 35/17, C12M 3/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 3.7.2024
Expires: 28.6.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 18.6.2025
Expires: 28.6.2026
Payer: Árnason Faktor ehf.